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Abstract: This study aims to determine differences in the on- and off-tumor microbiota between pa-
tients with right- and left-sided colorectal cancer. Microbiome profiling of tumor and tumor-adjacent
biopsies from patients with right-sided (n = 17) and left-sided (n = 7) colorectal adenocarcinoma was
performed using 16S ribosomal RNA sequencing. Off-tumor alpha and beta diversity were signif-
icantly different between right- and left-sided colorectal cancer patients. However, no differences
in on-tumor diversity were observed between tumor locations. Comparing the off-tumor micro-
biota showed the right colon to be enriched with species of the Lachnoclostridium, Selenomonas,
and Ruminococcus genera. Whereas the left colon is enriched with Epsilonbacteraeota phylum,
Campylobacteria class, and Pasteurellales and Campylobacterales orders, in contrast, the on-tumor
microbiota showed relatively fewer differences in bacterial taxonomy between tumor sites, with
left tumors being enriched with Methylophilaceae and Vadin BE97 families and Alloprevotella,
Intestinibacter, Romboutsia, and Ruminococcus 2 genera. Patients with left-sided colorectal cancer
had large taxonomic differences between their paired on- and off-tumor microbiota, while patients
with right-sided colorectal cancer showed relatively fewer taxonomic differences. Collectively, this
suggests that the right and left colon show distinctive bacterial populations; however, the presence of
a colonic tumor leads to a more consistent microbiota between locations.
Keywords: right- and left-sided colorectal cancer; gut microbiome; 16S rRNA; tumor microbiota;
proximal and distal colon
1. Introduction
The term colorectal cancer encompasses a heterogeneous group of tumors of the lower
gastrointestinal tract. Cancer location can be defined in relation to the colonic splenic
flexure (Figure 1), with tumors of the caecum, ascending and transverse colon, termed
right-sided colorectal cancer, and tumors of the descending colon, sigmoid colon, and the
rectum, termed left-sided colorectal cancer [1,2]. The right and left colon have distinctive
embryological origins, developing from the midgut and hindgut, respectively [3]. These
two anatomical colonic locations are supplied by different blood supplies, with the right
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colon being supplied by the superior mesenteric artery and the left colon being supplied
by the inferior mesenteric artery [3,4].




Figure 1. Schematic diagram of the right and left colon in relation to the colonic splenic flexure. The right colon (green) 
consists of the caecum, ascending, and transverse colon and the left colon (red) consists of the descending colon, sigmoid 
colon, and rectum. 
Previous studies have attempted to determine differences in the gut microbiota be-
tween right- and left-sided colorectal cancer [10,11]. Flemer et al. (2017) showed that there 
was no observable difference between the on- and off-tumor microbiota, along with show-
ing that the on-tumor microbiota from the right and left colon were significantly different 
[10]. However, as subsequently discussed by Al-Hassi et al. (2018), patients with right-
sided colorectal tumors more commonly develop iron deficiency anemia relative to those 
with left-sided tumors, hence more often requiring iron therapy [12]. Enteral iron supple-
mentation, often given to treat anemia, has been shown to alter the colonic microbiota, 
potentially through increasing gut luminal iron availability for bacterial cell proliferation 
[13]. The occurrence of iron deficiency anemia and the use of enteral iron supplementation 
was not assessed by the authors in the Flemer study and has the possibility to be account-
able for differences observed [10]. Therefore, when assessing the gut microbiota in colo-
rectal cancer, ensuring consistency in the prevalence of iron deficiency anemia and iron 
therapy is essential [14,15]. 
To our knowledge, this pilot study is the first to assess both the tumor-associated and 
tumor-adjacent microbiota between right- and left-sided colorectal cancer patients, while 
ensuring consistency in the prevalence of iron deficiency anemia and iron therapy. All 
colorectal cancer patients included in this study had iron deficiency anemia and received 
parenteral iron therapy prior to surgery. Parenteral iron therapy was given in order to 
Figure 1. Schematic diagram of the right and left colon in relation to the colonic splenic flexure. The right colon (green)
consists of the caecum, ascending, and transverse colon and the left colon (red) consists of the descending colon, sigmoid
colon, and rectum.
Disparities between the right and left colon translate into observable differences in
molecular and clinical characteristics between tumors in these locations. These include
right-sided tumors more commonly associated with microsatellite instability, being highly
immunogenic, and presenting with BRAF mutations. Whereas, left-sided tumors present
with chromosomal instability, often showing mutations in APC, P53, and SMAD4, and are
associated with amplified epidermal growth factor receptor signaling [5]. These differences
may be accountable for the variability in cancer incidence and prognosis between tumor
locations. With right-sided tumor patients tending to have a lower incidence with more
advanced tumors and worse prognosis, compared to the left-sided tumor. Furthermore,
right-sided tumors are more common in older females, whereas left-sided tumors are more
frequent in younger males [1,5]. With right- and left-sided colorectal tumors presenting
with such differences, further understanding the biological mechanisms underpinning
cancer initiation and progression, and how these differ between the right and left colon,
can aid in disease prevention and treatment.
A multistep pathogenesis is involved in the etiology of sporadic colorectal tumors,
with genetics, lifestyle, and environment all known to contribute to colorectal carcinogene-
sis [6]. Along with this, the gut bacterial microbiota and their metabolites have also been
shown to both promote and protect against colorectal cancer [7]. Therefore, identifying the
bacterial populations in the tumor-associated (on-tumor) and tumor-adjacent (off-tumor)
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microbiota, and how they differ between the right and left colon, has the potential to be
beneficial in predicting disease outcomes and aid in patient stratification [8,9].
Previous studies have attempted to determine differences in the gut microbiota be-
tween right- and left-sided colorectal cancer [10,11]. Flemer et al. (2017) showed that
there was no observable difference between the on- and off-tumor microbiota, along with
showing that the on-tumor microbiota from the right and left colon were significantly
different [10]. However, as subsequently discussed by Al-Hassi et al. (2018), patients with
right-sided colorectal tumors more commonly develop iron deficiency anemia relative
to those with left-sided tumors, hence more often requiring iron therapy [12]. Enteral
iron supplementation, often given to treat anemia, has been shown to alter the colonic
microbiota, potentially through increasing gut luminal iron availability for bacterial cell
proliferation [13]. The occurrence of iron deficiency anemia and the use of enteral iron sup-
plementation was not assessed by the authors in the Flemer study and has the possibility to
be accountable for differences observed [10]. Therefore, when assessing the gut microbiota
in colorectal cancer, ensuring consistency in the prevalence of iron deficiency anemia and
iron therapy is essential [14,15].
To our knowledge, this pilot study is the first to assess both the tumor-associated and
tumor-adjacent microbiota between right- and left-sided colorectal cancer patients, while
ensuring consistency in the prevalence of iron deficiency anemia and iron therapy. All
colorectal cancer patients included in this study had iron deficiency anemia and received
parenteral iron therapy prior to surgery. Parenteral iron therapy was given in order to limit
the influence of increasing gut iron concentration on the gut microbiota, associated with
enteral iron therapy [13,16].
2. Materials and Methods
2.1. Study Population and Sample Collection
Twenty-four anemic patients with non-metastatic histologically proven colorectal
adenocarcinoma, presenting with right-sided (n = 17) and left-sided (n = 7) tumors, from the
intravenous iron in colorectal cancer associated anemia (IVICA) trial, were included in the
study. All patients selected for this study received intravenous iron (ferric carboxymaltose—
Ferinject ™; Vifor Pharma, Glattbrugg, Switzerland) prior to surgery, dosed by weight and
hemoglobin in accordance with the summary of product characteristics [17]. Treatment was
administered at least 14 days preoperatively, with any pre-existing oral iron supplements
being discontinued at this point. Anemia was defined as having a hemoglobin level at least
10 g/L below the sex-specific World Health Organization definition (women ≤ 120 g/L,
men ≤ 130 g/L). Patients were excluded from the study if they were currently receiving
chemotherapeutic treatment, had anemia prior to colorectal cancer diagnosis, or pre-
existing hematological disease. Detailed patient demographics can be found in Table 1.
Colorectal tumor biopsies and paired tumor-adjacent colonic mucosal tissue biopsies were
obtained post-surgery.
2.2. DNA Extraction and 16S Ribosomal RNA Amplicon Sequencing
Bacterial DNA was obtained using a modified protocol of Qiagen All Prep DNA/RNA
Mini Kit (Qiagen, Hilden, Germany). Colorectal tumor and paired tumor-adjacent biopsies
were mechanically lysed using 5 mm steel bead (Qiagen) and 0.1 mm Zirconia/Silica beads
(Strateck, Suffolk, UK) with a TissueLyser (Qiagen), followed by enzymatic and heat lysis.
Extracted microbial DNA was used for 16S ribosomal RNA (rRNA) gene amplification
and sequencing to determine the mucosal-adherent microbiota according to the Earth
Microbiome project protocol [18]. Using primers targeted to the V4 region (515F-806R),
the 16S rRNA genes were amplified in technical triplicates. This was performed using
a single-step, single-indexed polymerase chain reaction (PCR). DNA extraction and 16S
rRNA gene PCR were both performed in batch with appropriate multiple-reagent based
negative controls. Paired-end sequencing (2 × 250 base pairs) was completed in a single
batch using the Illumina MiSeq platform (Illumina, San Diego, CA, USA).
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Table 1. Patient cohort demographics. Categorical variables are presented with percentages. Continuous variables are
presented as mean value [standard deviation] or * median value [interquartile range]. Hb, hemoglobin. CR-POSSUM,
ColoRectal Physiological and Operative Severity Score for the enumeration of Mortality and morbidity. ASA, American
Society of Anesthesiologist.
Patient Characteristics Right-Sided Colorectal Cancer (n = 17) Left-Sided Colorectal Cancer (n = 7)
Age 75.3 [7.5] 74 [7.7]
Male 9 (53%) 7 (100%)
Female 8 (47%) 0 (0%)
Height, m 1.67 [0.08] 1.77 [0.08]
Weight, kg 75.6 [12.8] 88.5 [24.0]
Inclusion Hb, g/L 97.1 [14.1] 102.9 [10.0]
Recruitment ferritin, µg/L * 25 [15–55] 10 [8–49]
Recruitment transferrin saturation, % * 2.6 [2.3–3.6] 2.8 [2.6–3.3]
Duration of iron treatment, days * 21 [15–35] 28 [15–43]
Tumor Stage
T ≤ 2 1 (6%) 0 (0%)
T3 3 (18%) 5 (71%)
T4 13 (76%) 2 (29%)
Preoperative Risk Assessment
ASA fitness status classification
I–II 7 (41%) 2 (29%)
III–IV 10 (59%) 5 (71%)
CR-POSSUM mortality score, % * 3.5 [2.5–9.3] 3.5 [2.6–6.6]
2.3. Statistical Analysis
Microbial bioinformatic analysis was achieved using the Quantitative Insight Into
Microbial Ecology 2 (QIIME2) pipeline [19]. High-quality reads were clustered into op-
erational taxonomic units (OTUs), reads with a 99% sequence identity were allocated
to a single OTU and were assigned bacterial taxonomy using the Silva-132-99% OTU
database [20]. Alpha diversity was assessed using the Mann–Whitney U test comparing
variation in Abundance-based Coverage Estimator (ACE), Chao1, and observed OTUs
between groups. Beta diversity was assessed using permutational multivariate analysis of
variance (PERMANOVA) comparing Jaccard similarity coefficients, with distances between
groups plotted using principal coordinate analysis (PCoA). PCoA and alpha diversity met-
rics were mapped using the R package “ggplot2” [21]. Comparisons of relative abundances
of taxa between locations and sample types were assessed using a linear discriminant anal-
ysis (LDA) effect size (LEfSe). LEfSe uses a non-parametric Kruskal–Wallis rank-sum test
to identify taxa with significantly different normalized relative abundances and performs
an LDA to determine an effect size of each taxon. Taxa with an LDA greater than 2 with a
p-value ≤ 0.05 were considered significant [22].
3. Results
3.1. On- and Off-Tumor Bacterial Diversity between the Right and Left Colon
A total of 4.4 million reads (an average of 109,122 reads/sample) were obtained fol-
lowing quality control, a sampling depth of 8000 reads/sample was chosen following
rarefaction. Comparison of alpha diversity metrics shows that the off-tumor microbiota
of patients with right-sided colorectal cancer showed significantly greater ACE (Bacterial
Abundance), Observed OTUs (Species Richness), and Chao1 (Bacterial Diversity), com-
pared to left-sided colorectal cancer patients (Figure 2; p < 0.05). Consistent with this, the
Jaccard similarity assessed beta diversity, showing that the off-tumor microbiota of right-
and left-sided colorectal cancer patients formed significantly distinct bacterial community
clusters (Figure 3a; p = 0.003). In contrast, the on-tumor microbiota showed no differences
in alpha diversity between right- and left-sided colorectal cancer patients (Figure 2; ns).
Furthermore, no significant differences in beta diversity were observed between right-
and left-sided colorectal tumors (Figure 3b; ns). Collectively this suggests that bacterial
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diversity is greater in the right colon compared to the left; however, the presence of a
colonic tumor leads to a more consistent bacterial diversity between locations.
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Figure 2. On- and off-tumor alpha diversity between right and left colon. Alpha diversity metrics (a) Abundance-based 
coverage estimate (ACE), (b) Observed operational taxonomic units (OTUs), and (c) Chao1 were significantly greater in 
the right compared to the left off-tumor microbiota. On-tumor alpha diversity metrics showed no significant differences 
between tumor locations. (* p ≤ 0.05, **p ≤ 0.01, ns p > 0.05). 
p=0.003 ns
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Figure 3. On- and off-tumor beta diversity between right and left colon. Principle coordinate analysis (PCoA) plots based 
on Jaccard distances show significantly distinct bacterial community clusters (p = 0.003) between the off-tumor microbiota 
from the right and left colon (a). On-tumor microbiota from the right and left colon show no significant differences (ns) 
(b). 
3.2. Gut Phylogenetic Profiles between Right- and Left-Sided Colorectal Cancer Patients 
Firmicutes, Bacteroides, Proteobacteria, and Fusobacteria constitute >95% of bacteria 
phyla in each group, showing largely consistent phylum relative abundance between lo-
cations (Figure 4a). The 3 most dominant bacterial families across all locations were Lach-
nospiraceae, Ruminococcaceae, and Bacteroidaceae. However, there is variation in the subse-
quent most abundant families between locations. Within the off-tumor microbiota, the 
next most abundant family was Fusobacteriaceae, followed by Enterobacteriaceae in the right 
colon and Prevotellaceae in the left colon. While in the on-tumor microbiota the next most 
abundant family is Prevotellaceae, followed by Streptococcaceae in the right-sided tumor and 
Rikenellaceae in the left-sided tumors (Figure 4b). 
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between tumor locations. (* p ≤ 0.05, ** p ≤ 0.01, ns p > 0.05).
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Figure 3. On- and off-tumor beta diversity between right and left colon. Principle coordinate analysis (PCoA) plots based
on Jaccard distances show significantly distinct bacterial co munity clusters (p = 0.003) between the off-tumor icrobiota
from the right and left colon (a). On-tumor icrobiota from the right and left colon show no significant differences (ns) (b).
3.2. Gut Phylogenetic Profiles between Right- and Left-Sided Colorectal Cancer Patients
Firmicutes, Bacteroides, Proteobacteria, and Fusobacteria constitute >95% of bacteria
phyla in each group, showing largely consistent phylum relative abundance between
locations (Figure 4a). The 3 most dominant bacterial families across all locations were
Lachnospiraceae, Ruminococcaceae, and Bacteroidaceae. However, there is variation in the
sub equent most abundant families between locations. Within the off-tumor microbiota,
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the next most abundant family was Fusobacteriaceae, followed by Enterobacteriaceae in the
right colon and Prevotellaceae in the left colon. While in the on-tumor microbiota the next
most abundant family is Prevotellaceae, followed by Streptococcaceae in the right-sided tumor
and Rikenellaceae in the left-sided tumors (Figure 4b).
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sided colorectal cancer patients (Figure 5c,d). Collectively, these results support the diver-
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by location, supporting a cancer-defined microbiota that is more constant between the 
right and left colon. 
Figure 4. On- and off-tumor phylogenetic profiles of gut bacterial populations in the right and left colon. Relative abundance
of on- and off-tumor mucosal adherent gut bacterial microbiota at phylum (a) and family (b) taxonomic levels in right and
left colon.
3.3. Comparison of Bacterial Taxa between the Right and Left Colon
Differences in gut bacterial populations between right- and left-sided colorectal can-
cer pati ts were assessed using LEfSe to det rmine bacterial taxa that are significantly
enriched b tween location . The off-tumor microbiota of right-sided colorectal cancer
patients showed greater abundances of species of the Lachnoclostridium, Selenomonas, and
Ruminococcus genera. Whereas, the off-tumor microbiota of left-sided colorectal cancer
patients is enriched with Epsilonbacteraeota phylum, Campylobacteria class, Pasteurel-
lales and Campylobacterales orders, Campylobacteraceae, Bacillales Family XI, Clostridiales
Family XI, Peptostreptococcaceae and Pasteurellaceae families, and Campylobacter, Gemella,
Granulicatella, Parvimonas, Anaerosporobacter, Lachnospiraceae (UCG010), Peptostreptococcus,
Selenomonas, and Haemophilus genera (Figure 5a,b). The on-tumor microbiota of left-sided
cancer patients showed gre ter abundances of Methylophilaceae and Vadin BE97 families
d Alloprevote la, Intestinibacter, Romboutsia, and R inococcus 2 genera, compared to
right-sided colorectal cancer patients (Figure 5c,d). Collectively, these results support
the diversity data, with the off-tumor microbiota showing large differences in bacterial
populations between the right and left colon. In contrast, the on-tumor microbiota seems
less affected by location, supporting a cancer-defined microbiota that is more constant
between the right and left colon.
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Figure 5. Linear discriminant analysis (LDA) effect size (LEfSe) comparing right and left bacterial taxa in the on- and
off-tumor microbiota. Histograms of LDA scores for differentially abundant bacterial taxa between right and left colon in
off-tumor (a) and on-tumor (c). LEfSe cladogram representing differentially abundant bacterial groups in off-tumor (b) and
on-tumor (d) microbiota between right and left colon. Differentially abundant taxa at the genus taxonomic levels or higher
were included. Taxa and nodes highlighted in green were more significant in the right colon and red in the left colon.
3.4. Differ nce in Paired On- and O f-T acterial Taxa in Right- and Left-Sided Colorectal
Cancer Patients
In order to assess the differences in bacterial taxa between the tumor-associated and
tumor-adjacent microbiotas in each location, we performed a LEfSe comparing paired
on- and off-tumor bacterial taxa in right- and left-sided colorectal cancer patients. In the
left-sided colorectal cancer patients, 24 bacterial taxa were differentially enriched between
the on- and off-tumor microbiota. These include the Lachnoclostridium genus which was
enriched in the on-tumor microbiota and the Cyanobacteria phylum, Melainabacteria
class, Gastra aerophilales, and Cory ebacteriales rders, Dietziaceae, Corynebacteri eae, Eg-
gerthellaceae. Rikenellaceae and Clostridiales vadin BB60 group families, Dietzia, Paraprevotella,
Prevotella 9, Alistipes, Lachnospira, Ruminococcus torques group, Paeniclostridium, Eubacterium
coprostanoligenes group, Acidaminococcus and Aquabacterium genera which were enriched
in the off-tumor microbiota (Figure 6c,d). In the right-sided colorectal cancer patients,
there were 3 bacterial taxa differentially enriched between the on- and off-tumor micro-
biota. These include the Porphyromonadaceae family, and Lachnospira and Porphyromonas
genera, which were more abundant in the on-tumor compared to the off-tumor microbiota
(Figure 6a,b). Collectively, this sugg sts that patients with r ght-si ed colorectal c nc r
have an on- and off-tumor micr biota that is relatively consistent, sh wing nly small
differences in bacterial taxa lower taxonomic levels. In contrast, patients with left-sided
colorectal cancer have an on- and off-tumor microbiota that shows distinct bacterial popu-
lations, showing differences at the phylum, class, and order taxonomic levels.
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left colon. These differences in off-tumor bacterial populations between the right and left 
colon are potentially explained by differences in colonic nutrient availability. Nutrient 
availability is greatest in the proximal colon and decreases towards the distal colon, 
through nutrients being reabsorbed in the colon and being utilized by residential bacteria 
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bacteria between the right and left colon, which may explain why the right colon shows 
greater bacterial diversity compared to the left [24]. Out of the 29 bacterial taxa that were 
differentially enriched within the off-tumor microbiota, 26 taxa were significantly en-
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4. Discussion
Previous studies have attempted to unravel the complex relationship between gut
bacteria and colorectal cancer [9,10]. However, the composition of the colonic microbiota
can be influenced by a multitude of variables, such as medication. Hence, this leaves the
potential for the study of the gut icrobiota in pathological conditions to be confounded
by discrepancies in therapeutic interventions [14,15]. To the best of our kno ledge, this
study is the first ti e that the colonic on- and off-tu or icrobiota has been studied in
right- and left-sided colorectal cancer patients ith iron deficiency ane ia.
is st s o s t at t e o - a off-t or icro iota et ee ri t- a left-si e
c l r ct l cancer patients show differential microbial diversity and bacterial t xa. Off-
tumor alpha diversity is significantly greater in right- compared to left-sided colorectal
ancer patients, showing gr ater bacterial diversity, abundance, and richne s. Further ore,
f eta diversity shows ignificantly different bacterial community clusters b tween
right- and left-sid d colorecta cancer pati nts. Comparison of off-tumor axonomy shows
t ere to be 29 bacterial taxa tha are differentially enriched betwe n the right and left colon.
These differences n off-tumor bac erial populations betwee th right and left colon are
pote tially expla ned by differences in colo ic nutrient availabil ty. Nutrient availability is
greatest in the proximal colon and decreases towards th distal colon, through nutrients
being reabsorbed in the colon and being utilized by residential bacteria [23]. Therefore,
this pot ntially creates differential nutrient niches available for colonic b ct ria between
the right and l ft colon, which may explain w y the right colon shows reater bacterial
diversity compared to the left [24]. Out of the 29 bacterial taxa that were differentially
enriched withi the off-tumor microbiota, 26 taxa were significantly enriched within the
left colon. With the potential differences in nutrient niches between the right and left colon,
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these bacterial taxa may be specially adapted to thrive within the potentially nutrient-
deprived environment within the left colon. Whereas they may be outcompeted by more
dominant bacteria that thrive in the potential nutrient-rich environment in the right colon.
These more specialized taxa within the left colon may dominate the microbiota, explaining
why a lower bacterial diversity may be present. Whereas in the right colon there is a
greater number of bacteria which are more evenly spread, contributing to greater bacterial
diversity. However, as less of these bacterial taxa dominate, this leads them to not being as
significantly enriched when compared to the left colon. In contrast, the on-tumor microbiota
shows no differences in alpha and beta diversity between right- and left-sided colorectal
cancer patients. Comparison of on-tumor taxonomy shows there to be 8 bacterial taxa
that are differentially enriched between the right and left colon. Collectively, this suggests
that the on-tumor microbiota between right- and left-sided colorectal cancer patients are
relatively more consistent when compared to the differences observed in the off-tumor
microbiota, suggesting that the on-tumor microbiota between the right and left colon is
not as influenced by colonic nutrient availability, potentially supporting a cancer-defined
microbiota that is less affected by tumor location.
Cancer-associated microbiota are influenced by the tumor microenvironment, and this
is regulated by many factors, such as the mucosal immune system, genetic and epigenetic
factors, and vascular infiltration. How the cancer-associated microbiota develops depends
on these factors, all of which are also altered between the right and left colon. Hence, this
leaves the potential for alterations between the on- and off-tumor microbiota to be differ-
entially regulated between patients with right- and left-sided colorectal tumors [5,7,11].
Comparison of bacterial taxa between paired on- and off-tumor microbiota showed that
patients with right-sided colorectal cancer had a relatively consistent on- and off-tumor
microbiota, with only 3 bacterial taxa being differentially enriched. In contrast patients
with left-sided colorectal cancer had a more varied on- and off-tumor microbiota, showing
24 differentially enriched bacterial taxa. This supports a previous study by Thomas et al.
(2016) comparing the microbiota of rectal (left-sided) cancer patients and healthy con-
trols. The authors showed there to be significant differences in bacterial taxa and diversity
between cancerous and healthy rectal microbiota [25]. Collectively this implies that the
tumor-defined microbiota may be more consistent to the microbiota found in the right
colon compared to the left. Suggesting that there is a shift in the left tumor microbiota
away from the typical microbiota found in the left colon, becoming more similar to the
right colonic microbiota. Along with patients with right-sided colorectal cancer developing
symptoms later, this may also explain why right-sided tumors tend to be more advanced
and larger compared to left-sided tumors, as the right colonic microbiota is primed to
support colorectal cancer progression [1].
Previous studies comparing the microbiota between the right and left colon, such
as those by Flemer et al. (2017) and Gao et al. (2015), have presented differences in
the on-tumor microbiota between the proximal and distal colon. These studies have
accounted for medicinal intervention with antibiotics prior to surgery; however, neither
study assessed the prevalence of iron deficiency anemia or enteral iron therapy in their
cohort [10,11]. With iron deficiency anemia tending to be unequally prevalent between
right- and left-sided colorectal cancer patients, this may influence the differences observed
in the tumor microbiota between locations [26]. As enteral iron therapy has been shown
to alter the gut microbiota, this leaves the potential to present with differential bacterial
populations compared to patients treated with parenteral iron, or those who are not iron
deficient [13,16].
This pilot study provides a novel insight into the on- and off-tumor microbial profiles
between right- and left-sided colorectal cancer patients. Suggesting a varied microbiota
between the right and left colon; however, the presence of a colonic tumor leads to a more
consistent cancer-defined microbiota. This is potentially through the left tumor microbiota
being more similar to the microbiota found in the right colon, suggesting that the right
colonic microbiota may be more favorable to support colonic tumors. Despite the relatively
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small sample size of this study, we were able to infer significant differences between right-
and left-sided colorectal cancer patients, which can form the foundation for further large-
scale explorative studies. Future studies may overcome some limitations of our study by
accounting for further confounding variables such as diet. As well as including a more
diverse study population, ensuring a more balanced spread of patient characteristics such
as gender and tumor stage between groups. Further clinical and translational work is
required to understand the influence of iron supplementation on the gut microbiota in right-
and left-sided colorectal cancer, how this can influence the stage of disease, and to assess
any causal relationship between colonic bacterial populations and oncological outcomes.
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